UCLA scientists provides further evidence that the brains of people with autism, despite different causes, tend to have the same molecular “signature.”
5-Dec-2016 1:05 PM EST Add to Favorites
The WORLD Policy Analysis Center at the UCLA Fielding School of Public Health produced a far-reaching analysis of countries’ efforts, since adoption of Convention on the Rights of Persons with Disabilities, to enact and address global rights, laws...
2-Dec-2016 6:00 AM EST Add to Favorites
Non-Invasive Brain Stimulation May Help People Manage Their Drive for Gambling, Sex, Alcohol or Overeating
UCLA study looks at theta burst stimulation as intervention in problem behaviors
29-Nov-2016 1:05 PM EST Add to Favorites
Conference offers presentations and a panel highlighting inclusive policies and practices promoting a welcoming environment, strong patient-provider relationships, and a safe space for women to disclose their sexual orientation, improving the...
22-Nov-2016 2:05 PM EST Add to Favorites
A special edition of the International Journal for Equity in Health, co-edited by UCLA’s James Macinko, highlights the beneficial role of Brazil’s universal healthcare, which has improved access to care and health outcomes. Can the U.S. learn...
18-Nov-2016 4:05 PM EST Add to Favorites
Drug Combination Therapy for Estrogen-Receptor–Positive Breast Cancer Passes Critical Step for Worldwide Approval
• Breakthrough drug palbociclib (brand name IBRANCE) targets a key family of proteins to prevent cell growth in cancer
• New UCLA-led study treated women with estrogen receptor positive (ER+), HER2-negative (HER2-) advanced breast cancer with a...
17-Nov-2016 10:05 AM EST Add to Favorites
As the world moves toward universal health coverage, the question arises: How can governments ensure equitable access to essential medicines in low- and middle-income countries? A section of The Lancet Commission on Essential Medicines Policies...
7-Nov-2016 7:05 PM EST Add to Favorites
Breakthrough Drug Extensively Evaluated by UCLA Scientist Approved as Alternative to Chemotherapy for People with Advanced Lung Cancer
Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for non-small cell lung cancer (NSCLC). The first-line...
25-Oct-2016 12:05 PM EDT Add to Favorites
UCLA Health experts are available to discuss a wide variety of topics of interest during this holiday season.
22-Nov-2016 1:05 PM EST
8-Nov-2016 6:05 PM EST
4-Nov-2016 2:05 PM EDT
UCLA Health experts are available to discuss a wide variety of topics of interest for the month of November.
1-Nov-2016 5:05 PM EDT
Queen Latifah and UCLA cardiologist Dr. Karol Watson discuss what patients and their caregivers need to know about living with heart failure.
25-Oct-2016 2:05 PM EDT
24-Oct-2016 4:05 PM EDT
UCLA expert is available for interviews about the Centers for Disease Control and Prevention’s new STD statistics
19-Oct-2016 7:05 PM EDT
A UCLA psychiatrist weighs in on steps we can take to keep our calm – and our friends and family – in this highly charged political climate.
17-Oct-2016 3:10 PM EDT